Salivary Gland Scintigraphy in Parotid-Sparing IMRT for H&N Cancer: Trend of Function Recovery
Alessia Reali, Tiziana Angusti, Edoardo Trevisiol, Simona Allis et autres
it (code pays fourni par la source)
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
Alessia Reali, Tiziana Angusti, Edoardo Trevisiol, Simona Allis et autres
it (code pays fourni par la source)
Simona Dinicola, Andrea Fuso, A Cucina, M Santiago-Reyes et autres
OBJECTIVE: Cancer patients frequently experience Chemotherapy-Induced Peripheral Neuropathy (CIPN), as a typical side effect related to time of administration and dose of anticancer agents. Yet, CIPN pathophysiology is poorly understood, and there is a lack of well-tolerated pharmacological remedies helpful to prevent …
it (code pays fourni par la source)
Pierfrancesco Franco, Francesca Arcadipane, Elisabetta Trino, Elena Gallio et autres
OBJECTIVE: Delineation of treatment volumes is a major source of uncertainties in radiotherapy (RT). This is also true for rectal cancer patients undergoing neoadjuvant RT, with a potential impact on treatment quality. We investigated the role of the digital platform Anatom-e (Anatom-e …
it (code pays fourni par la source)
Lavinia Bianco, SilviaMaria Anglesio, Roberta Verna, Davide Torti et autres
Extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue (MALT) are low-grade B-cell neoplasms, which arise in mucosal sites with prolonged lymphoid proliferation. Primary tracheal MALT lymphoma is an exceedingly rare entity for which the optimal treatment approach has not been determined. Here, …
it (code pays fourni par la source)
Alessia Reali, Simona Allis, Andrea Girardi, Roberta Verna et autres
AIM: Brain metastases (BMs) are a common event in the progression of many human cancers. The aim of this study was to evaluate the potential prognostic factors for the clinical identification of a subgroup of patients that could benefit from whole brain …
it (code pays fourni par la source)
MariaGrazia Ruo Redda, Alessia Reali, Simona Allis, SilviaMaria Anglesio et autres
it (code pays fourni par la source)
Maria Grazia Ruo Redda, Silvia Maria Anglesio, Simona Allis, Roberta Verna et autres
it (code pays fourni par la source)
Michele Nagliati, Andrea Bolner, Valentina Vanoni, Luigi Tomio et autres
AIMS AND BACKGROUND: Major salivary gland cancers are rare, with many histologic types and subtypes. The low incidence and heterogeneity of primary parotid carcinomas makes their outcome difficult to evaluate. Treatment remains primarily surgical, but optimal therapeutic regimens have yet to be …
it, gb (code pays fourni par la source)
Maria Grazia Ruo Redda, Roberta Verna, Alessia Guarneri, Gian Luca Sannazzari
it (code pays fourni par la source)
Gian Luca Sannazzari, Maria Grazia Ruo Redda, Monica Rampino, Roberta Verna
Locoregional control of primary tumor is fundamental to cure since only in one third of patients the onset of distant metastases is the major cause of therapeutic failure. Thus recently, all therapeutic approaches aimed at the enhancement of locoregional control have been …
it (code pays fourni par la source)
Gian Luca Sannazzari, Pietro Gabriele, Maria Grazia Ruo Redda, Roberta Verna
In recent years, the improvement in results in terms of survival in the treatment of laryngeal and hypopharyngeal cancer at the same stage has been rather poor. Therefore, oncologists have tried to improve the quality of life through a decrease in morbidity …
it (code pays fourni par la source)
Umberto Ricardi, Giuseppe Rossi, M. Tessa, E Barisone et autres
it (code pays fourni par la source)
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.
L'essentiel de l'actu tech du Burkina & d'Afrique, chaque semaine dans votre boîte mail.
Gratuit · sans spam · désinscription en un clic